William R. Bensch

2.1k total citations · 1 hit paper
18 papers, 1.6k citations indexed

About

William R. Bensch is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, William R. Bensch has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in William R. Bensch's work include Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Estrogen and related hormone effects (4 papers). William R. Bensch is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Estrogen and related hormone effects (4 papers). William R. Bensch collaborates with scholars based in United States and Brazil. William R. Bensch's co-authors include Raymond F. Kauffman, George J. Cullinan, Raymond A. Bendele, Masahiko Sato, Larry J. Black, Ellen R. Rowley, D. Clive Williams, A Bekele, David E. Magee and Robert J. Schmidt and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Biochemical and Biophysical Research Communications.

In The Last Decade

William R. Bensch

18 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

1994 506 citations Larry J. Black, Masahiko Sato et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by William R. Bensch

Since Specialization

Citations

This map shows the geographic impact of William R. Bensch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Bensch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Bensch more than expected).

Fields of papers citing papers by William R. Bensch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Bensch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Bensch. The network helps show where William R. Bensch may publish in the future.

Co-authorship network of co-authors of William R. Bensch

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Bensch. A scholar is included among the top collaborators of William R. Bensch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Bensch. William R. Bensch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Identification and Characterization of a Major Liver Lysophosphatidylcholine Acyltransferase 2008 ·Journal of Biological Chemistry ·Yang Zhao, Yan Chen, Tabetha M. Bonacci, David S. Bredt, Shuyu Li, William R. Bensch, David E. Moller, Mark C. Kowala, Robert J. Konrad, Guoqing Cao	159
2	Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo 2008 ·Biochemical and Biophysical Research Communications ·Robert J. Schmidt, Thomas P. Beyer, William R. Bensch, Yuewei Qian, Aiming Lin, Mark C. Kowala, William E. Alborn, Robert J. Konrad, Guoqing Cao	85
3	Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis 2007 ·Journal of Lipid Research ·Yuewei Qian, Robert J. Schmidt, Youyan Zhang, Shaoyou Chu, Aimin Lin, He Wang, Xiliang Wang, Thomas P. Beyer, William R. Bensch, Weiming Li, Mariam Ehsani, Deshun Lu, Robert J. Konrad, Patrick I. Eacho, David E. Moller, Sotirios K. Karathanasis, Guoqing Cao	194
4	Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 Diabetes 2006 ·Endocrinology ·Yanfang Liu, (unknown), Shera Kash, William R. Bensch, Brett P. Monia, Susan F. Murray, Keith A. Otto, Samreen K. Syed, Sanjay Bhanot, Kyle W. Sloop, John M. Sullivan, Anne Reifel‐Miller	95
5	Identification of a Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic Acid (LY518674), That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 Expression 2005 ·Molecular Pharmacology ·Jai Singh, Raymond F. Kauffman, William R. Bensch, Guoming Wang, (unknown), James S. Bean, Chahrzad Montrose, Nathan B. Mantlo, (unknown)	20
6	Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in Vivo 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Thomas P. Beyer, Robert J. Schmidt, Patricia Foxworthy, Youyan Zhang, Jiannong Dai, William R. Bensch, Raymond F. Kauffman, Hong Gao, Timothy P. Ryan, Xian‐Cheng Jiang, Sotirios K. Karathanasis, Patrick I. Eacho, Guoqing Cao	34
7	Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression 2003 ·Journal of Biological Chemistry ·Xian‐Cheng Jiang, Thomas P. Beyer, Zhiqiang Li, Jin Liu, (unknown), Robert J. Schmidt, Youyan Zhang, William R. Bensch, Patrick I. Eacho, Guoqing Cao	41
8	Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist 2003 ·Journal of Medicinal Chemistry ·Yanping Xu, (unknown), (unknown), Xiaodong Wang, R. C. Thompson, (unknown), Raymond F. Kauffman, (unknown), James S. Bean, William R. Bensch, Robert J. Barr, John J. Osborne, Chahrzad Montrose‐Rafizadeh, Richard W. Zink, Nathan Yumibe, (unknown), Debra Luffer‐Atlas, Deepa Rungta, (unknown), Nathan B. Mantlo	52
9	Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo 2002 ·Journal of Biological Chemistry ·Guoqing Cao, Thomas P. Beyer, Xiao Yang, Robert J. Schmidt, Youyan Zhang, William R. Bensch, Raymond F. Kauffman, Hong Gao, Timothy P. Ryan, Liang Yu, Patrick I. Eacho, Xian‐Cheng Jiang	146
10	Raloxifene and Estrogen Inhibit Neointimal Thickening After Balloon Injury in the Carotid Artery of Male and Ovariectomized Female Rats 2000 ·Journal of Cardiovascular Pharmacology ·Raymond F. Kauffman, James S. Bean, (unknown), George J. Cullinan, David A. Cox, William R. Bensch	18
11	Effects of LY295427, a Low-Density Lipoprotein (LDL) Receptor Up-Regulator, on LDL Receptor Gene Transcription and Cholesterol Metabolism in Normal and Hypercholesterolemic Hamsters 1999 ·Journal of Pharmacology and Experimental Therapeutics ·William R. Bensch, Robert A. Gadski, James S. Bean, Lisa S. Beavers, R J Schmidt, (unknown), (unknown), (unknown), Patrick I. Eacho, Alan P. Breau, Robert A. Archer, Raymond F. Kauffman	14
12	Hypocholesterolemic Activity of Raloxifene (LY139481): Pharmacological Characterization as a Selective Estrogen Receptor Modulator 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Raymond F. Kauffman, William R. Bensch, Roger E. Roudebush, Harlan W. Cole, James S. Bean, Diane L. Phillips, Amy Monroe, George J. Cullinan, Andrew L. Glasebrook, Henry U. Bryant	48
13	Synthesis and Biological Evaluation of a New Series of Sterols as Potential Hypocholesterolemic Agents 1995 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Robert A. Archer, Joseph M. Pawlak, Lisa S. Beavers, Robert J. Schmidt, Raymond F. Kauffman, William R. Bensch, Thomas F. Bumol	22
14	Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. breakdown → 1994 ·Journal of Clinical Investigation ·Larry J. Black, Masahiko Sato, Ellen R. Rowley, David E. Magee, A Bekele, D. Clive Williams, George J. Cullinan, Raymond A. Bendele, Raymond F. Kauffman, William R. Bensch	506
15	Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution. 1994 ·Journal of Lipid Research ·Glenn F. Evans, William R. Bensch, L D Apelgren, Dana Bailey, Raymond F. Kauffman, Thomas F. Bumol, Steven H. Zuckerman	27
16	[56] S-3-hydroxy-3-methylglutaryl-CoA reductase from Pseudomonas 1981 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Victor W. Rodwell, William R. Bensch	6
17	Lack of correlation between the rate of cholesterol biosynthesis and the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rats and in fibroblasts treated with ML-236B 1978 ·Biochemical and Biophysical Research Communications ·William R. Bensch, Thomas S. Ingebritsen, (unknown)	47
18	Purification and Properties of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase from Pseudomonas 1970 ·Journal of Biological Chemistry ·William R. Bensch, Victor W. Rodwell	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact